Diane Dodgen, MD
Emergency Medicine · Perry, FLNPI 1134117385
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $598 and has fallen 97.3% since, to $16 in 2023. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $16.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$177
- Novo Nordisk$142
- Pfizer$141
- Amarin Pharma, Inc.$123
- Lilly USA, LLC$117
- Merck$86
- plus $615 from 15 others
What the payments were for
- Food & beverage$1,402100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $177 |
| Novo Nordisk | 10 | $142 |
| Pfizer | 9 | $141 |
| Amarin Pharma, Inc. | 7 | $123 |
| Lilly USA, LLC | 8 | $117 |
| Merck | 5 | $86 |
| Sanofi-aventis U.S. LLC | 5 | $84 |
| Johnson & Johnson | 5 | $67 |
| Eisai Inc. | 4 | $64 |
| Supernus Pharmaceuticals, Inc. | 4 | $61 |
| Jazz Pharmaceuticals Inc. | 3 | $54 |
| Novartis | 3 | $52 |
| Amgen | 3 | $43 |
| AbbVie | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Melinta Therapeutics, LLC | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| GSK | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| PBG Puerto Rico LLC | 1 | $12 |
How this compares
$1,402 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $42,774 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $32,875 |
| JanuviaSitagliptin Phosphate | 30 | $15,974 |
| MyrbetriqMirabegron | 40 | $12,542 |
| XareltoRivaroxaban | 16 | $11,722 |
| JardianceEmpagliflozin | 12 | $9,780 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $3,672 |
| Levothyroxine Sodium | 307 | $3,098 |
| FarxigaDapagliflozin Propanediol | 11 | $2,678 |
| Atorvastatin Calcium | 284 | $2,573 |
| Potassium Chloride | 128 | $2,548 |
| Omeprazole | 153 | $2,348 |
| Gabapentin | 115 | $1,768 |
| Buspirone Hcl | 108 | $1,737 |
| Amlodipine Besylate | 222 | $1,733 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $141 | $42,77485 claims |
| GSKTrelegy Ellipta | $20 | $32,87535 claims |
| MerckJanuvia | $86 | $15,97430 claims |
| Johnson & JohnsonXarelto | $67 | $11,72216 claims |
| AstraZenecaFarxiga | $177 | $2,67811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,289 emergency medicine providers in Florida.
Other emergency medicine in Perry
- Laurent DreyfussSunrise$1.2M
- Jason WilsonTampa$538K
- Robert LutenJacksonville$190K
- Adam LeisyHialeah$148K
- Joseph TyndallGainesville$130K
- Kunal AgarwalMiami$101K
- Jason WilsonFort Myers$96K
- Latha GantiGainesville$86K
- Brandon AllenGainesville$80K
- Patricia PanakosMiami$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.